221 related articles for article (PubMed ID: 34258611)
1. Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.
Alagoz O; Lowry KP; Kurian AW; Mandelblatt JS; Ergun MA; Huang H; Lee SJ; Schechter CB; Tosteson ANA; Miglioretti DL; Trentham-Dietz A; Nyante SJ; Kerlikowske K; Sprague BL; Stout NK;
J Natl Cancer Inst; 2021 Nov; 113(11):1484-1494. PubMed ID: 34258611
[TBL] [Abstract][Full Text] [Related]
2. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
[TBL] [Abstract][Full Text] [Related]
3. Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic.
Sprague BL; Lowry KP; Miglioretti DL; Alsheik N; Bowles EJA; Tosteson ANA; Rauscher G; Herschorn SD; Lee JM; Trentham-Dietz A; Weaver DL; Stout NK; Kerlikowske K
J Natl Cancer Inst; 2021 Sep; 113(9):1161-1167. PubMed ID: 33778894
[TBL] [Abstract][Full Text] [Related]
4. Impact of the COVID-19 pandemic on a population-based breast cancer screening program.
Peng SM; Yang KC; Chan WP; Wang YW; Lin LJ; Yen AM; Smith RA; Chen TH
Cancer; 2020 Dec; 126(24):5202-5205. PubMed ID: 32914864
[No Abstract] [Full Text] [Related]
5. The use of telemedicine to maintain breast cancer follow-up and surveillance during the COVID-19 pandemic.
Sonagli M; Cagnacci Neto R; Leite FPM; Makdissi FBA
J Surg Oncol; 2021 Feb; 123(2):371-374. PubMed ID: 33333581
[TBL] [Abstract][Full Text] [Related]
6. The COVID-19 BreastScreen Department - beyond the pandemic.
Spuur KM
J Med Radiat Sci; 2020 Dec; 67(4):352-355. PubMed ID: 33026711
[TBL] [Abstract][Full Text] [Related]
7. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
Plevritis SK; Munoz D; Kurian AW; Stout NK; Alagoz O; Near AM; Lee SJ; van den Broek JJ; Huang X; Schechter CB; Sprague BL; Song J; de Koning HJ; Trentham-Dietz A; van Ravesteyn NT; Gangnon R; Chandler Y; Li Y; Xu C; Ergun MA; Huang H; Berry DA; Mandelblatt JS
JAMA; 2018 Jan; 319(2):154-164. PubMed ID: 29318276
[TBL] [Abstract][Full Text] [Related]
8. The impact of the Covid-19 pandemic on breast cancer early detection and screening.
; Figueroa JD; Gray E; Pashayan N; Deandrea S; Karch A; Vale DB; Elder K; Procopio P; van Ravesteyn NT; Mutabi M; Canfell K; Nickson C
Prev Med; 2021 Oct; 151():106585. PubMed ID: 34217412
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 pandemic on breast cancer screening in a large midwestern United States academic medical center.
Johnson KJ; O'Connell CP; Waken RJ; Barnes JM
PLoS One; 2024; 19(5):e0303280. PubMed ID: 38768115
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.
Chung A; Chen Q; Curry W; Felix T; Tuan WJ
Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260
[TBL] [Abstract][Full Text] [Related]
11. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis.
Ward ZJ; Walbaum M; Walbaum B; Guzman MJ; Jimenez de la Jara J; Nervi B; Atun R
Lancet Oncol; 2021 Oct; 22(10):1427-1437. PubMed ID: 34487693
[TBL] [Abstract][Full Text] [Related]
12. Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology.
van den Broek JJ; van Ravesteyn NT; Mandelblatt JS; Cevik M; Schechter CB; Lee SJ; Huang H; Li Y; Munoz DF; Plevritis SK; de Koning HJ; Stout NK; van Ballegooijen M
Med Decis Making; 2018 Apr; 38(1_suppl):112S-125S. PubMed ID: 29554471
[TBL] [Abstract][Full Text] [Related]
13. Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive study.
Chiarelli AM; Walker MJ; Espino-Hernandez G; Gray N; Salleh A; Adhihetty C; Gao J; Fienberg S; Rey MA; Rabeneck L
CMAJ Open; 2021; 9(4):E1205-E1212. PubMed ID: 34933878
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation Model.
Birnbaum J; Gadi VK; Markowitz E; Etzioni R
Ann Intern Med; 2016 Feb; 164(4):236-43. PubMed ID: 26756332
[TBL] [Abstract][Full Text] [Related]
15. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada.
Malagón T; Yong JHE; Tope P; Miller WH; Franco EL;
Int J Cancer; 2022 Apr; 150(8):1244-1254. PubMed ID: 34843106
[TBL] [Abstract][Full Text] [Related]
16. Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years + .
Monsivais P; Amiri S; Robison J; Pflugeisen C; Kordas G; Amram O
Breast Cancer; 2022 Jul; 29(4):740-746. PubMed ID: 35366175
[TBL] [Abstract][Full Text] [Related]
17. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer statistics, 2011.
DeSantis C; Siegel R; Bandi P; Jemal A
CA Cancer J Clin; 2011; 61(6):409-18. PubMed ID: 21969133
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer deaths averted over 3 decades.
Hendrick RE; Baker JA; Helvie MA
Cancer; 2019 May; 125(9):1482-1488. PubMed ID: 30740647
[TBL] [Abstract][Full Text] [Related]
20. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.
Webb ML; Cady B; Michaelson JS; Bush DM; Calvillo KZ; Kopans DB; Smith BL
Cancer; 2014 Sep; 120(18):2839-46. PubMed ID: 24018987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
